IPOdesktop

About the Author IPOdesktop

During the IPO season Francis Gaskins, editor of IPOdesktop.com & director of research for Equities.com, regularly appears on CNBC TV, Bloomberg, thestreet.com & other financial cable channels. On the day of the Visa IPO he appeared on four cable TV financial shows including Bloomberg & CNBC. Over the past five years he has been quoted over 500 times by such financial media as the Wall Street Journal, Bloomberg, Reuters, Associated Press, USA Today among others. Those quotes are available at IPOdesktop.com. His varied personal interests include violin playing. For example, he is concertmaster of the Palisades Symphony. He also holds an MBA from Harvard Business School (finance) and an AB from Princeton University (economics).

IPO Preview: Bojangles’ Restaurants, Inc. (BOJA)

Based in Charlotte, NC, Bojangles’ Restaurants, Inc. (Pending:BOJA) scheduled a $100 million IPO on Nasdaq …

IPO Preview: Enviva Partners LP (EVA)

Based in Bethesda, MD, Enviva Partners LP (NYSE:EVA) scheduled a $200 million IPO on NYSE …

IPO Preview: Etsy Inc (ETSY)

Based in Brooklyn, NY, Etsy Inc (NASDAQ:ETSY) scheduled a $250 million IPO on Nasdaq with …

IPO Preview: GoDaddy

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate …

IPO Preview: Jernigan Capital Inc

Summary Funding of incoming self-storage mortgages with equity kickers depends on a successful IPO. No …

IPO Preview: SolarEdge Technologies Inc

Summary       A leading provider of intelligent inverter solutions that are changing the …

IPO Preview: ViewRay Inc

Summary Designs, manufactures and markets MRIdian, the first and only MRI-guided radiation therapy system to …

IPO Preview: Wowo Ltd

Based in Beijing, China, Wowo Ltd (Pending:WOWO) scheduled a ‘best efforts’ $60 million IPO on …

IPO Preview: Bellerophon Therapeutics

Based in Hampton, New Jersey, Bellerophon Therapeutics (Pending:BLPH) scheduled a $60 million IPO on Nasdaq …

IPO Preview: Invitae

Based in San Francisco, CA, Invitae (Pending:NVTA) scheduled a $75 million IPO on NYSE with …